HRTX Q1 2018 Earnings — Heron Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena

HRTXHeron Therapeutics, Inc.

$153M

Q1 2018 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$12M+218.5% YoY

Gross Profit

$8M72.9% margin

Operating Income

-$52M-449.5% margin

Net Income

-$52M-451.8% margin

EPS (Diluted)

$-0.81

QoQ Revenue Growth

+15.1%

Cash Flow

Operating Cash Flow

-$62M

Free Cash Flow

-$63M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$183M

Total Liabilities

$91M

Stockholders' Equity

$92M

Cash & Equivalents

$47M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$12M	$4M	+218.5%
Gross Profit	$8M	$2M	+244.8%
Operating Income	-$52M	-$49M	-5.5%
Net Income	-$52M	-$50M	-3.8%